-+ 0.00%
-+ 0.00%
-+ 0.00%

ALDEYRA THERAPEUTICS SHARES HIT RECORD LOW AFTER US FDA DECLINES TO APPROVE EYE DISORDER DRUG, LAST DOWN 70%

Reuters·03/17/2026 13:49:04

Please log in to view news